Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
IQVIA Holdings, Inc. Common Stock
(NY:
IQV
)
258.08
-1.90 (-0.73%)
Delayed Quote
Updated: 3:23 PM EDT, Oct 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about IQVIA Holdings, Inc. Common Stock
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
January 31, 2023
From
IQVIA
Via
Business Wire
IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023
January 25, 2023
From
IQVIA
Via
Business Wire
Will Investors Notice Exciting Sign On IQVIA Hldgs's Chart?
↗
January 23, 2023
Via
Benzinga
Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute
January 18, 2023
From
IQVIA
Via
Business Wire
Analyst Ratings for IQVIA Hldgs
↗
January 13, 2023
Via
Benzinga
Expert Ratings for IQVIA Hldgs
↗
December 06, 2022
Via
Benzinga
Where IQVIA Hldgs Stands With Analysts
↗
November 17, 2022
Via
Benzinga
Analyst Ratings for IQVIA Hldgs
↗
November 17, 2022
Via
Benzinga
World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday
↗
January 17, 2023
Goldman Sachs boosted the price target for The Wendy's Company (NASDAQ: WEN) from $22 to $25. Goldman Sachs analyst Jared Garber maintained a Neutral rating on the stock. Wendy's shares fell 1.4% to...
Via
Benzinga
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
↗
January 11, 2023
These healthcare companies' revenue and earnings have grown, and they expect more growth.
Via
The Motley Fool
Veracyte Stock Showing Market Leadership; Earns 93 RS Rating
↗
December 01, 2022
Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings
↗
November 17, 2022
Piper Sandler boosted the price target on Target Corporation (NYSE: TGT) from $190 to $200. Target shares fell 13.1% to close at $155.47 on Wednesday.
Via
Benzinga
IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel
November 10, 2022
From
IQVIA
Via
Business Wire
8 Analysts Have This to Say About IQVIA Hldgs
↗
October 27, 2022
IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings within the last quarter:
Via
Benzinga
7 Analysts Have This to Say About IQVIA Hldgs
↗
October 06, 2022
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
↗
December 06, 2022
Via
Benzinga
General Electric To Rally Around 14%? Here Are 5 Other Price Target Changes For Thursday
↗
October 27, 2022
Morgan Stanley raised General Electric Company (NYSE: GE) price target from $85 to $88. Morgan Stanley analyst Joshua Pokrzywinski maintained the stock with an Overweight rating. GE shares rose 2.2%...
Via
Benzinga
Expert Ratings for IQVIA Hldgs
↗
September 12, 2022
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:
Via
Benzinga
6 Analysts Have This to Say About IQVIA Hldgs
↗
September 12, 2022
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
↗
November 17, 2022
Upgrades
Via
Benzinga
IQVIA: Q3 Earnings Insights
↗
October 26, 2022
IQVIA Hldgs (NYSE:IQV) reported its Q3 earnings results on Wednesday, October 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IQVIA Hldgs beat estimated...
Via
Benzinga
IQVIA Reports Third-Quarter 2022 Results
October 26, 2022
From
IQVIA Holdings Inc.
Via
Business Wire
Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies
↗
October 25, 2022
Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.
Via
Investor's Business Daily
Biosimilars Are Revolutionizing Healthcare: Is This Industry Leader a Buy?
↗
October 25, 2022
Biosimilars are bringing down prescription drug costs without sacrificing quality.
Via
The Motley Fool
IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022
October 24, 2022
From
IQVIA Holdings Inc.
Via
Business Wire
Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso
October 06, 2022
From
IQVIA
Via
Business Wire
Tesla To $370? Plus HC Wainwright Slashes PT On This Stock By 67%
↗
October 06, 2022
HC Wainwright & Co. cut KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) price target from $48 to $16. KalVista Pharmaceuticals shares fell 1.8% to $5.06 in pre-market trading.
Via
Benzinga
IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022
October 03, 2022
From
IQVIA Holdings Inc.
Via
Business Wire
IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation
September 28, 2022
From
IQVIA
Via
Business Wire
New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials
September 07, 2022
From
IQVIA
Via
Business Wire
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
